Titus Boggon, PhD
Associate Professor of Pharmacology and of Molecular Biophysics and Biochemistry
Biography
Research & Publications
News
Locations
Appointments
Biography
Dr. Boggon is a structural biologist interested in the molecular basis of cytosolic signal transduction cascades. He completed his Ph.D. at the University of Manchester, U.K., and postdoctoral studies at Mount Sinai School of Medicine, Columbia University and the Dana-Farber Cancer Institute (at Harvard Medical School). His lab is interested in understanding how RhoGTPase signal transduction pathways are regulated at the molecular level, and the molecular basis for acquisition of a cerebrovascular disorder, Cerebral Cavernous Malformations (CCM).
Education & Training
- PhDUniversity of Manchester, UK (1998)
- BSUniversity of Manchester, UK (1995)
- Research FellowHarvard Medical School and Dana-Farber Cancer Institute
- Postdoctoral ScientistColumbia University
- Postdoctoral FellowMount Sinai School of Medicine
Departments & Organizations
- Biochemistry, Quantitative Biology, Biophysics and Structural Biology (BQBS)
- Cancer Signaling Networks
- Molecular Biophysics and Biochemistry
- Molecular Medicine, Pharmacology, and Physiology
- Office of Cooperative Research
- Pharmacology
- Primary Faculty
- Structural Biology
- Vascular Biology and Therapeutics Program
- WHRY Pilot Project Program Investigators
- Yale Cancer Center
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)